Stay updated on ARGX-113 in Myasthenia Gravis: Safety Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Safety Trial page
- Check4 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check11 days agoChange DetectedThe ClinicalTrials.gov study page is showing a 403 Forbidden response instead of its study content.SummaryDifference0.2%

- Check18 days agoChange DetectedThe study record view displays a 403 Forbidden message and a Home link instead of study details.SummaryDifference0.5%

- Check31 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study record content with an access-denied message. The header and navigation remain visible while the detailed trial information is not accessible.SummaryDifference17%

- Check53 days agoChange DetectedAn NIH grant/contract reference was added under Other Study ID Numbers. The page revision tag was updated from v3.6.5 to v3.6.6, replacing the previous version.SummaryDifference0.1%

- Check74 days agoChange DetectedThe footer revision label was updated from v3.6.4 to v3.6.5. This indicates a small software revision of the page and does not alter study data.SummaryDifference0.0%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Safety Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Safety Trial page.